About Lombard Medical (NASDAQ:EVAR)
Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company's Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Symbol: NASDAQ:EVAR
- CUSIP: N/A
- Web: www.lombardmedical.com
- Market Cap: $11.6 million
- Outstanding Shares: 27,950,000
- 50 Day Moving Avg: $0.45
- 200 Day Moving Avg: $0.50
- 52 Week Range: $0.39 - $0.95
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $12.17 million
- Price / Sales: 0.90
- Book Value: $0.50 per share
- Price / Book: 0.78
- Average Volume: 51,114 shs.
- Beta: 1.17
- Short Ratio: 0.7
Frequently Asked Questions for Lombard Medical (NASDAQ:EVAR)
What is Lombard Medical's stock symbol?
Lombard Medical trades on the NASDAQ under the ticker symbol "EVAR."
How were Lombard Medical's earnings last quarter?
Lombard Medical, Inc. (NASDAQ:EVAR) issued its quarterly earnings results on Thursday, October, 27th. The company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.11. The business had revenue of $3.04 million for the quarter, compared to analyst estimates of $3.16 million. View Lombard Medical's Earnings History.
Who are some of Lombard Medical's key competitors?
Some companies that are related to Lombard Medical include Capnia (SLNO), Surgical Innovations Group Plc (SUN), Alliqua BioMedical (ALQA), Cytori Therapeutics (CYTX), Tandem Diabetes Care (TNDM), NeuroMetrix (NURO), InspireMD (NSPR), CareFusion (CFN), Covidien Ltd (COV), CRH Medical Corp (CRHM), CRH Medical Corp (CRHM), CRH Medical Corp (CRHM), Great Basin Scientific (GBSN), LDR Holding Corp (LDRH) and Syneron Medical (ELOS).
Who are Lombard Medical's key executives?
Lombard Medical's management team includes the folowing people:
- Simon Hubbert, Chief Executive Officer, Director
- William J. Kullback, Chief Financial Officer
- Peter Phillips, Chief Technology Officer
- Raymond Wayne Cohen, Non-Executive Independent Chairman of the Board
- David B. Milne, Director
- Michael H. Carrel, Non-Executive Director
- Timothy Haines, Independent Director
- Simon John Neathercoat, Senior Independent Director
How do I buy Lombard Medical stock?
Shares of Lombard Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Lombard Medical's stock price today?
MarketBeat Community Rating for Lombard Medical (NASDAQ EVAR)MarketBeat's community ratings are surveys of what our community members think about Lombard Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Lombard Medical stock can currently be purchased for approximately $0.39.
Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Lombard Medical (NASDAQ:EVAR)
Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
(Data available from 10/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|8/23/2016||BTIG Research||Reiterated Rating||Hold||N/A|
|8/23/2016||Barclays PLC||Lower Price Target||Equal Weight||$2.50 -> $1.00||N/A|
Earnings History for Lombard Medical (NASDAQ:EVAR)Earnings History by Quarter for Lombard Medical (NASDAQ EVAR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/27/2016||Q3||($0.27)||($0.37)||$3.16 million||$3.04 million||View||N/A|
|8/22/2016||Q2145||($0.40)||($0.42)||$3.78 million||$3.80 million||View||Listen|
|5/11/2016||Q1||($0.41)||($0.38)||$3.52 million||$2.90 million||View||Listen|
|2/22/2016||Q415||($0.40)||($0.58)||$3.25 million||$2.94 million||View||Listen|
|11/4/2015||Q315||($0.53)||($0.45)||$4.65 million||$4.20 million||View||N/A|
|7/27/2015||Q215||($0.55)||($0.51)||$4.46 million||$4.54 million||View||Listen|
|5/11/2015||Q1145||($0.57)||($0.59)||$3.20 million||$3.41 million||View||Listen|
|2/26/2015||Q4||($0.46)||($0.51)||$4.80 million||$4.80 million||View||N/A|
|10/29/2014||Q314||($0.79)||($0.52)||$2.14 million||$4.30 million||View||N/A|
|8/11/2014||Q2 2014||($0.52)||($0.86)||$2.40 million||$2.19 million||View||N/A|
Earnings Estimates for Lombard Medical (NASDAQ:EVAR)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Lombard Medical (NASDAQ:EVAR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Lombard Medical (NASDAQ:EVAR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Lombard Medical (NASDAQ:EVAR)
Latest Headlines for Lombard Medical (NASDAQ:EVAR)
Loading headlines, please wait.
Lombard Medical (EVAR) Chart for Saturday, October, 21, 2017